The pandemic has already claimed too many lives in the United States and around the world, but fortunately, as doctors become more delighted in the treatment of coronavirus disease 2019 (COVID-19), more hospitalized people will recover. vital question: what do you think of recovery?
Because COVID-19 is still a new condition, there is not yet much knowledge to answer this question, but a recent examination of 55 other people recovering from COVID-19 in China provides an early review of lung service as recovery [1]. Obviously, the effects show that even in other people with mild to moderate infection, the effects of COVID-19 can persist in the lungs for months. In fact, 3 months after leaving the hospital, about 70% of the participants examined continued to have lung scans. , indicating that the lungs are still broken and seeking healing.
The effects of EClinicalMedicine come from a team in Henan Province, China, led by Aiguo Xu, the first affiliated hospital at Zhengzhou University; Yanfeng Gao, Zhengzhou University; and Hong Luo, Guangshan People’s Hospital. They had heard of lung abnormalities in patients discharged from the hospital, but the duration of these disorders is unclear.
To find out, investigators recruited 55 men and women who had been admitted to the hospital with COVID-19 3 months earlier; some of the participants, whose average age was 48, had other physical fitness problems, such as diabetes or central illness, but none. had pre-existing lung problems.
Most patients had hospitalization for mild to moderate respiratory disease. Only 4 of the 55 were classified as seriously ill. Fourteen patients required more oxygen during their hospital stay, but none required mechanical ventilation.
Three months after discharge from the hospital, all patients had to return to work. But they continued to have persistent symptoms of COVID-19, adding shortness of breath, cough, gastrointestinal problems, headaches or fatigue.
Evidence of this ongoing challenge also gave the impression on his lungs. Thirty-nine of the participants examined had an abnormal result on their CT scan, which creates photographs that cut off the lungs. Tests.
Interestingly, researchers found that people with longer-lasting lung disorders also had higher grades of D-dimer, a piece of protein that occurs when a blood clot dissolves. They recommend that a D-dimer test can identify others with COVID -19 who would benefit from pulmonary rehabilitation to reconstruct their lung function, even in the absence of severe respiratory symptoms.
This location also influences how SARS-CoV-2 virus appears to have a tendency to blood clotting, a factor that is addressed in our public-private partnership accelerating therapeutic interventions and COVID-19 (ACTIV) vaccines. The association recently introduced a trial on anticoagulants. This trial will begin by focusing on newly diagnosed outpatients and hospitalized patients, but then come with a convalescence-like component.
In the future, longer-term and larger-scale studies on COVID-19 recovery in others from diverse backgrounds will be vital to continue to be more informed about what COVID-19 means. imply that for many other people who have been hospitalized by COVID-19, recovery from the general lung might take some time. As we are further told about the underlying reasons and long-term consequences of this new infectious disease, hopefully it will soon lead to data that will help many more long-distance COVID-19s and their relatives involved breathe better.
Reference:
[1] A lung follow-up exam serves as related physiological characteristics of COVID-19 survivors 3 months after recovery. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, Gao YF, Xu AG. EClinicalMedicine, 25 August 2020: 100463
Links:
Coronavirus (COVID-19) (NIH)
How the lungs work (National Heart, Lung and Blood Institute / NIH)
Computer Tomography (CT) (National Institute of Bioengineering and Biomedical Imaging / NIH)
Zhengzhou University (Zhengzhou City, Henan Province, China)
Accelerate curative interventions and COVID-19 (ACTIV) vaccines (NIH)
covid-19, anywhere, in any country, it’s scary
Another peculiar comment by Lynne . . . 1) Is there an opportunity for continuous evaluation of patients related to viral lung cancer sponsorship?(e. g. HPV/cervical cancer) 2) Is there an option of SARS/Covid 19 as opposed to attendance?Hemophiliacs? Just a thought . . .
Lung pain heals, it only takes time:
CT scans at 6 weeks showed lung damage due to coronavirus-induced inflammation and fluid buildup, which occurs as ‘ground glass’ patches, in 88% of patients. At 12 weeks, this measure fell to 56%. The severity of overall lung damage was reduced from 8 problems on the 6-week CT scans to four problems on the 12-week CT scans.
“There is also an improvement in lung service from 6 to 12 weeks of follow-up. “
Recovery of ALL unhealthy patients enough to be hospitalized would possibly take some time. If we looked at influenza hospitalizations and lung service in the same way, would we expect to find the same results?Do we even know? The tone of this piece turns out to imply a reluctance to settle for intelligent news.
A domain of interest is the difference in air quality in various countries. We seem cleaner than before, would the difference in air quality make those 55 patients if they were tested here after having COVID-19?
That’s why other people are so afraid of this virus. If you have this virus, your lungs won’t be the same as before.
Lung cells have broken through COVID and just want time to heal and update broken surfaces.
I visited my pneumologist last week, who is very involved with the recovery of Covid 19 patients she attends, she claims that the recoveries appear to be widespread in almost every case, that patients are experiencing more and more unforeseen effects of the virus, and was surprised by the number of younger patients who had the virus and the serious aftermath that also has , is heavily involved in what he calls the virus politicization with the other resulting coverage measures. This from St. Petersburg, Florida.
I @TheNASciences for the virtual rite – TempletonPrize2020 which starts at 7 p. m. ET tonight; I am deeply honored . . . https://t. co/YKCKU9hHRJ 4 days ago
Controlling diabetes can be difficult. Find out how @salkinstitute scientists mix #cancerinmunotherapy and . . . https://t. co/3eGu4KpDi5 4 days ago
Join me (24/09) at 12:10 p. m. ET on Facebook and Twitter for a live update on the Array-related COVID19 vaccine. https://t. co/G6gC2Tp32I five days ago
Kendall Morgan, Ph. D.
If you have any questions or questions unrelated to ongoing discussions, refer them to Ask NIH.
You are encouraged to express your opinion and your percentage ideas. See the NIH comment policy